OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
59
Results
Show all
Save search
Copy query
Show results for
Unknown
(59)
Publication Date
Release Date
2021
(15)
2025
(12)
2022
(11)
2024
(8)
2020
(4)
2023
(3)
2018
(2)
2017
(2)
2019
(1)
2016
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis.
Not available
S-EPMC5571502
|
biostudies-literature
Cite
Prevalence of workplace violence against nurses in Saudi Arabia: A systematic review and meta-analysis.
Not available
S-EPMC12504953
|
biostudies-literature
Cite
Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.
Not available
S-EPMC10848368
|
biostudies-literature
Cite
Outcomes of CAR T-Cell therapy in relapsed/refractory multiple myeloma by race: a multicenter real-world study.
Not available
S-EPMC12638965
|
biostudies-literature
Cite
Prevalence and risk factors of functional seizures among adult Sudanese patients with epilepsy, a cross-sectional clinic-based study.
Not available
S-EPMC9577850
|
biostudies-literature
Cite
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774
|
biostudies-literature
Cite
Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.
Not available
S-EPMC11618392
|
biostudies-literature
Cite
Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents.
Not available
S-EPMC11521986
|
biostudies-literature
Cite
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957
|
biostudies-literature
Cite
The second survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and temporal changes in care (STARS-2 program).
Not available
S-EPMC12404464
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets